R. Brett McQueen
R. Brett McQueen
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Email verificata su ucdenver.edu
Titolo
Citata da
Citata da
Anno
Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes
DB Price, M Romn-Rodrguez, RB McQueen, S Bosnic-Anticevich, ...
The Journal of Allergy and Clinical Immunology: In Practice 5 (4), 1071-1081. e9, 2017
1952017
Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates
JD Campbell, V Ghushchyan, RB McQueen, S Cahoon-Metzger, ...
Multiple sclerosis and related disorders 3 (2), 227-236, 2014
1082014
Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey
KV Nair, DA Belletti, JJ Doyle, RR Allen, RB McQueen, JJ Saseen, ...
Patient preference and adherence 5, 195, 2011
812011
Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
RB McQueen, SL Ellis, JD Campbell, KV Nair, PW Sullivan
Cost effectiveness and resource allocation 9 (1), 1-8, 2011
672011
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis
MD Whittington, RB McQueen, DA Ollendorf, JA Tice, RH Chapman, ...
Annals of Allergy, Asthma & Immunology 118 (2), 220-225, 2017
582017
Cost-effectiveness of biological asthma treatments: a systematic review and recommendations for future economic evaluations
RB McQueen, DN Sheehan, MD Whittington, JFM van Boven, ...
Pharmacoeconomics 36 (8), 957-971, 2018
492018
Long-term survival and value of chimeric antigen receptor T-cell therapy for pediatric patients with relapsed or refractory leukemia
MD Whittington, RB McQueen, DA Ollendorf, VM Kumar, RH Chapman, ...
JAMA pediatrics 172 (12), 1161-1168, 2018
402018
The “e” in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence
JD Campbell, RB McQueen, A Briggs
Annals of the American Thoracic Society 11 (Supplement 2), S105-S111, 2014
332014
Economic differences in direct and indirect costs between people with epilepsy and without epilepsy
AM Libby, V Ghushchyan, RB McQueen, JF Slejko, JL Bainbridge, ...
Medical care, 928-933, 2012
302012
Long-term survival and cost-effectiveness associated with axicabtagene ciloleucel vs chemotherapy for treatment of B-cell lymphoma
MD Whittington, RB McQueen, DA Ollendorf, VM Kumar, RH Chapman, ...
JAMA network open 2 (2), e190035-e190035, 2019
272019
On-and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
T Morrisette, MA Miller, BT Montague, GR Barber, RB McQueen, M Krsak
Journal of Antimicrobial Chemotherapy 74 (8), 2405-2416, 2019
232019
Long-acting lipoglycopeptides:“lineless antibiotics” for serious infections in persons who use drugs
T Morrisette, MA Miller, BT Montague, GR Barber, RB McQueen, M Krsak
Open forum infectious diseases 6 (7), ofz274, 2019
232019
Cost-effectiveness uncertainty analysis methods: a comparison of one-way sensitivity, analysis of covariance, and expected value of partial perfect information
JD Campbell, RB McQueen, AM Libby, DE Spackman, JJ Carlson, ...
Medical Decision Making 35 (5), 596-607, 2015
212015
An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures
JA Pesa, J Van Den Bos, T Gray, C Hartsig, RB McQueen, JJ Saseen, ...
Patient preference and adherence 6, 63, 2012
202012
Economic burden of comorbid chronic kidney disease and diabetes
RB McQueen, S Farahbakhshian, KF Bell, KV Nair, JJ Saseen
Journal of medical economics 20 (6), 585-591, 2017
182017
Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation
JP Vande Griend, RB McQueen, SA Linnebur, SF Vondracek
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (2…, 2012
182012
Can economic model transparency improve provider interpretation of cost-effectiveness analysis? Evaluating tradeoffs presented by the Second Panel on Cost-effectiveness in…
WV Padula, RB McQueen, PJ Pronovost
Medical care 55 (11), 909-911, 2017
172017
Economic grand rounds: psychological distress and depression associated with job loss and gain: the social costs of job instability
AM Libby, V Ghushchyan, RB McQueen, JD Campbell
Psychiatric services 61 (12), 1178-1180, 2010
162010
Association between glycated hemoglobin and health utility for type 1 diabetes
RB McQueen, SL Ellis, DM Maahs, HD Anderson, KV Nair, AM Libby, ...
The Patient-Patient-Centered Outcomes Research 7 (2), 197-205, 2014
132014
Incremental increases in economic burden parallels cardiometabolic risk factors in the US
RB McQueen, V Ghushchyan, T Olufade, JJ Sheehan, KV Nair, JJ Saseen
Diabetes, metabolic syndrome and obesity: targets and therapy 9, 233, 2016
122016
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20